Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient - a case report

Annals of Transplantation

Volumn 19, Issue 1, 2014, Pages 60-63

  Ciszek, Michał ^a   Mucha, Krzysztof ^a   Foroncewicz, Bartosz ^a   Chmura, Andrzej ^a   Paczek, Leszek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

CMV infection; Kidney transplantation; Leflunomide therapy

Indexed keywords

GANCICLOVIR; IMMUNOGLOBULIN G; LEFLUNOMIDE; MEPREDNISONE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; VALGANCICLOVIR; VIRUS DNA;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; GANCICLOVIR RESISTANT CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; LOOSE FECES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; URETER CATHETER; VIRUS LOAD;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; GANCICLOVIR; GRAFT REJECTION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS; ISOXAZOLES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SALVAGE THERAPY; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84894081346     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.884035     Document Type: Article

References (8)

1. Kabat-Koperska J, Ke{ogonek}dzierska K, Gołembiewska E et al: Three clinical cases of nonrespiratory acidosis in kidney transplant recipients receiving anti-CMV therapy. Ann Transplant, 2012; 17: 135-40
2. Chacko B, John GT: Leflunomide for cytomegalovirus: bench to bedside. Transpl Infect Dis, 2012; 14: 111-20
3. Smolen JS, Landewé R, Breedveld FC et al: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological diseasemodifying antirheumatic drugs. Ann Rheum Dis, 2010; 69: 964-75
4. Waldman WJ, Knight DA, Blinder L et al: Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology, 1999; 42: 412-18
5. Waldman WJ, Knight DA, Lurain NS et al: Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation, 1999; 68: 814-25
6. Chong AS, Zeng H, Knight DA et al: Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant, 2006; 6: 69-75
7. Avery RK, Bolwell BJ, Yen-Lieberman B et al: Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplant, 2004; 34: 1071-75
8. Avery RK, Mossad SB, Poggio E et al: Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes. Transplantation, 2010; 90: 419-26